Welcome to Paid Research Studies




  • Condition:   Breast Cancer
    Interventions:   Combination Product: LightPath® Imaging System and 68Ga-RM2;   Drug: 68Ga-RM2
    Sponsor:   Lightpoint Medical Limited
    Not yet recruiting

  • Conditions:   Breast Cancer;   Invasive Ductal Breast Carcinoma;   Invasive Lobular Breast Carcinoma
    Intervention:   Diagnostic Test: Radiomic, pathomic, and clinical markers
    Sponsor:   Sunnybrook Health Sciences Centre
    Active, not recruiting

  • Condition:   Breast Neoplasm
    Intervention:   Device: MRI
    Sponsor:   Assiut University
    Not yet recruiting

  • Conditions:   Anatomic Stage I Breast Cancer AJCC v8;   Anatomic Stage IA Breast Cancer AJCC v8;   Anatomic Stage IB Breast Cancer AJCC v8;   Anatomic Stage II Breast Cancer AJCC v8;   Anatomic Stage IIA Breast Cancer AJCC v8;   Anatomic Stage IIB Breast Cancer AJCC v8;   Anatomic Stage III Breast Cancer AJCC v8;   Anatomic Stage IIIA Breast Cancer AJCC v8;   Anatomic Stage IIIB Breast Cancer AJCC v8;   Anatomic Stage IIIC Breast Cancer AJCC v8;   Breast Fibrocystic Change;   Ductal Breast Carcinoma In Situ;   Estrogen Receptor Negative;   HER2/Neu Negative;   Invasive Breast Carcinoma;   Lobular Breast Carcinoma In Situ;   Progesterone Receptor Negative;   Prognostic Stage I Breast Cancer AJCC v8;   Prognostic Stage IA Breast Cancer AJCC v8;   Prognostic Stage IB Breast Cancer AJCC v8;   Prognostic Stage II Breast Cancer AJCC v8;   Prognostic Stage IIA Breast Cancer AJCC v8;   Prognostic Stage IIB Breast Cancer AJCC v8;   Prognostic Stage III Breast Cancer AJCC v8;   Prognostic Stage IIIA Breast Cancer AJCC v8;   Prognostic Stage IIIB Breast Cancer AJCC v8;   Prognostic Stage IIIC Breast Cancer AJCC v8;   Triple-Negative Breast Carcinoma
    Interventions:   Drug: Abemaciclib;   Procedure: Therapeutic Conventional Surgery
    Sponsors:   Mayo Clinic;   National Cancer Institute (NCI)
    Not yet recruiting

  • Condition:   Node-positive Breast Cancer
    Interventions:   Diagnostic Test: Systematic axillary ultrasound imaging;   Diagnostic Test: Sentinel node;   Procedure: Excision of suspicious lymph nodes;   Procedure: Two steps axillary node clearance
    Sponsors:   Parc de Salut Mar;   GEICAM
    Not yet recruiting

  • Conditions:   Breast Cancer;   Leptomeningeal Metastasis
    Interventions:   Procedure: Cerebrospinal fluid and blood sample collection at the initial diagnostic assessment;   Procedure: Cerebrospinal fluid and blood sample collection if conclusions of initial diagnostic assessment are "Lack of evidence" according to EANO-ESMO classification;   Procedure: Cerebrospinal fluid and blood sample collection if conclusions of initial diagnostic assessment are "confirmed", "probable" or "possible", leading to leptomeningeal metastase specific treatment
    Sponsor:   Centre Oscar Lambret
    Not yet recruiting

  • Condition:   Breast Cancer
    Interventions:   Other: Under- or overdiagnosed cancer;   Other: Screening
    Sponsors:   Cancer Registry of Norway;   Extrastiftelsen
    Active, not recruiting

  • Conditions:   Breast Cancer Female;   Stage I Breast Cancer;   Stage II Breast Cancer;   Stage III Breast Cancer;   Ductal Carcinoma in Situ;   Ductal Breast Carcinoma;   Lobular Breast Carcinoma
    Interventions:   Other: Breast reconstruction decision aid;   Other: Educational website
    Sponsors:   University of Texas at Austin;   Ohio State University;   Washington University School of Medicine
    Recruiting

  • Conditions:   Breast Fibroadenoma;   Atypical Ductal Hyperplasia;   Atypical Lobular Hyperplasia;   Lobular Carcinoma in Situ;   Flat Epithelial Atypia;   Phyllodes; Fibroadenoma;   Phyllodes Breast Tumor;   Radial Scar;   Breast Papilloma;   Complex Sclerosing Papillary Lesion of the Breast
    Interventions:   Procedure: Vacuum-assisted percutaneous excision;   Procedure: Open surgical excision
    Sponsor:   Lawson Health Research Institute
    Not yet recruiting